Medical cannabis needs careful, evidence-informed guidance

As medical cannabis becomes more widely legalized, clinicians are increasingly expected to guide patients despite limited and inconsistent evidence. The article examines cannabis as a possible treatment option across multiple conditions while emphasizing that its benefits must be weighed against risks, including psychosis, cannabinoid hyperemesis syndrome, and cannabis use disorder.

For patients, the central message is that medical cannabis should not be treated as risk-free or self-explanatory. Drug interactions, uncertainty in clinical decision making, and racial disparities all complicate care. The authors conclude that cannabis may have a role as an adjunct within patient-centered harm reduction, but only with appropriate screening, monitoring, and clinician education. The abstract reports no quantitative results, so it does not establish how effective cannabis is for any particular condition.